The Daily Start-Up: Third Time’s A Charm For Oceana Thera Investors
Oceana Therapeutics, which raised $102 million from investors, is being acquired for $300 million cash by publicly traded Salix Pharmaceuticals. Oceana raised its funding from private equity firm Kelso & Co and venture investor Frazier ...